Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 08-2015 | 06-2015 | 05-2015 | 03-2015 | 02-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,720 | -780 | -780 | -1,470 | N/A |
| Depreciation Amortization | 8 | 470 | 470 | 2,070 | N/A |
| Other Working Capital | 120 | 90 | 90 | 1,160 | N/A |
| Other Operating Activity | -948 | -550 | -550 | -8,170 | 0 |
| Operating Cash Flow | $-2,540 | $-770 | $-770 | $-6,410 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -100 | -100 | -100 | -30 | N/A |
| Other Investing Activity | 3,610 | 810 | 810 | 6,820 | 0 |
| Investing Cash Flow | $3,510 | $710 | $710 | $6,790 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -1 | 0 | 40 | 0 |
| Financing Cash Flow | $0 | $-1 | $0 | $40 | $N/A |
| Exchange Rate Effect | 40 | -2 | -2 | 140 | N/A |
| Beginning Cash Position | 1,020 | 1,050 | 1,050 | 600 | N/A |
| End Cash Position | 2,030 | 980 | 980 | 1,160 | N/A |
| Net Cash Flow | $1,010 | $-60 | $-60 | $560 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,540 | -770 | -770 | -6,410 | N/A |
| Free Cash Flow | -2,540 | -770 | -770 | -6,410 | 0 |